浙江榮泰(603119.SH):目前和全球眾多知名OEM汽車廠商均有廣泛業務合作
格隆匯3月8日丨浙江榮泰(603119.SH)近日在接待機構投資者調研時表示,公司不斷提升創新能力,整合多方創新資源,增強自主核心技術儲備,在新能源汽車、儲能等領域探索更多應用場景,適應客户需求推出新型輕量化安全結構件等新材料、新產品、新技術,創建公司特有的競爭優勢。公司目前和全球眾多知名OEM汽車廠商均有廣泛業務合作,主要客户包括特斯拉、大眾、寶馬、平治、沃爾沃、上汽集團、一汽集團等。公司持續通過新增生產設備及配套設施,有效提升公司新能源汽車熱失控防護絕緣件及新型輕量化安全結構件等產品的整體產能,有利於公司更好地發展新的客户,實現公司業務規模的進一步擴大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.